Characterizing Knee Pain and Response to Surgery Using Local Biomarkers

Sponsor
Stanford University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00961623
Collaborator
(none)
0
1
29
0

Study Details

Study Description

Brief Summary

The diagnosis and monitoring of clinically-significant pathologies of the knee remains challenging, and it is unknown why only some injuries become painful or respond to surgical intervention. The limitations of diagnostic magnetic resonance imaging result in arthroscopy that is not always beneficial. Elucidation of biochemical pathways underlying pain in this condition may aid patient selection for surgery and provide pharmacotherapeutic targets. Cytokines or a novel yet uncharacterized protein may be involved in pain following meniscus injury and diagnostic cytokine assay may help physicians differentiate patients that may benefit from arthroscopy from those that may not. Additionally, evaluating post-operative biochemical profiles may provide a method of monitoring surgical outcome and understanding post-operative continuation or remission of pain.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Lavage of the operative and contralateral knee for comparison are performed under anesthesia prior to arthroscopy by the infusion of 10cc sterile saline into the knee joint followed by the immediate withdrawal into the syringe, and storage at -80°C in a tube containing a protease inhibitor. At 12wk post-operative a 10cc lavage is performed on the knee that underwent surgery. Clinical findings for each sample are quantified using gold-standard symptom severity questionnaires.

    The specimens will be analyzed for 31 potential biomarkers using a multiplexed immunoassay panel, the results of which will be compared with pre- and post-operative clinical findings and radiographic imaging. Plans do not currently include microarray analysis, but this may be later included.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Characterizing Knee Pain and Response to Surgery Using Local Biomarkers
    Study Start Date :
    Jul 1, 2009
    Anticipated Primary Completion Date :
    Dec 1, 2011
    Anticipated Study Completion Date :
    Dec 1, 2011

    Outcome Measures

    Primary Outcome Measures

    1. Surgical outcome: pain and functionality [12-24wk post-operative.]

    Secondary Outcome Measures

    1. Expression profiles of inflammatory mediators [24wk]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    •Adult patients with knee pain (acute or chronic) who had failed conservative treatment and elected for arthroscopic management. Indications for surgery included the presence of mechanical symptoms on history, a physical examination positive for McMurray's maneuver or joint line tenderness or both, absence of severe joint space narrowing on plain radiography, and the presence of grade III signal changes on MRI in an anatomic location consistent with the history and physical examination.

    Exclusion Criteria:
    • Less than 18 years old.

    • Recent (within three months) intra-articular corticosteroid injection and past or current medical history of autoimmune disease (i.e. rheumatoid arthritis).

    • In addition, no patients involved in a worker's compensation claim or personal injury litigation were enrolled in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University School of Medicine Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University

    Investigators

    • Principal Investigator: Jason L Dragoo, MD, Stanford University
    • Study Chair: Eric Leroux, Stanford University
    • Study Chair: Amy Wasterlain, Stanford University
    • Principal Investigator: Gaetano Scuderi, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jason L. Dragoo, Principle Investigator, Stanford University
    ClinicalTrials.gov Identifier:
    NCT00961623
    Other Study ID Numbers:
    • SU-07292009-3441
    • IRB 16305
    First Posted:
    Aug 19, 2009
    Last Update Posted:
    Jun 4, 2019
    Last Verified:
    May 1, 2019
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 4, 2019